ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)
China · Delayed Price · Currency is CNY 37.24
+0.62 (1.69%)
Apr 29, 2026, 3:00 PM CST
ChengDu ShengNuo Biotec Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 177.13 | 157.89 | 50.02 | 70.34 | 64.48 | 61.25 |
Depreciation & Amortization | 56.54 | 56.54 | 34.56 | 27.65 | 24.69 | 18.26 |
Other Amortization | 1.47 | 1.47 | 1.19 | 1.49 | 1.27 | 0.49 |
Loss (Gain) From Sale of Assets | - | - | 0.59 | 0.91 | 0.39 | 4.89 |
Asset Writedown & Restructuring Costs | 16.16 | 16.16 | - | - | - | - |
Loss (Gain) From Sale of Investments | -1.96 | -1.96 | -1.87 | 1.42 | -2.48 | -1.51 |
Provision & Write-off of Bad Debts | - | - | 8.36 | 3.08 | 2.46 | 0.86 |
Other Operating Activities | -28.07 | 22.06 | 20.69 | 13.65 | 6.33 | 2.52 |
Change in Accounts Receivable | -79.14 | -79.14 | -49.96 | 9.82 | -22.22 | -17.6 |
Change in Inventory | -51.21 | -51.21 | -120.11 | -63.79 | -38.72 | -12.54 |
Change in Accounts Payable | 57.32 | 57.32 | 83.04 | 18.64 | 57.6 | -5.28 |
Change in Other Net Operating Assets | 2.8 | 2.8 | 4.21 | 2.85 | 1.12 | 1.11 |
Operating Cash Flow | 147.56 | 178.45 | 25.27 | 84.78 | 95.62 | 52.41 |
Operating Cash Flow Growth | 571.41% | 606.07% | -70.19% | -11.34% | 82.44% | -35.17% |
Capital Expenditures | -132.28 | -145.77 | -247.48 | -277.98 | -135.85 | -64.22 |
Sale of Property, Plant & Equipment | 0.1 | 0.1 | 0.05 | 0.33 | 0.13 | 0.11 |
Divestitures | 1.66 | 1.66 | - | - | - | - |
Investment in Securities | -65.37 | -46.92 | 13.45 | -93.4 | 152.3 | -209.9 |
Other Investing Activities | -73.5 | 0.53 | 3.15 | 1.75 | 4.38 | -7.9 |
Investing Cash Flow | -269.4 | -190.4 | -230.83 | -369.31 | 20.96 | -281.91 |
Long-Term Debt Issued | - | 437.91 | 302.58 | 216.7 | 100 | 30 |
Total Debt Issued | 545.91 | 437.91 | 302.58 | 216.7 | 100 | 30 |
Long-Term Debt Repaid | - | -413.03 | -82.29 | -57.94 | -30.93 | -1.93 |
Total Debt Repaid | -432.35 | -413.03 | -82.29 | -57.94 | -30.93 | -1.93 |
Net Debt Issued (Repaid) | 113.56 | 24.88 | 220.29 | 158.75 | 69.07 | 28.07 |
Issuance of Common Stock | - | - | 6.58 | - | - | 310 |
Common Dividends Paid | -37.62 | -36 | -34.17 | -29.18 | -26.82 | -0.03 |
Other Financing Activities | 64.52 | 71.45 | -0.2 | 0.18 | - | -25.85 |
Financing Cash Flow | 140.46 | 60.33 | 192.51 | 129.75 | 42.25 | 312.2 |
Foreign Exchange Rate Adjustments | -1.36 | -0.76 | 0.68 | 0.5 | 3 | -0.67 |
Net Cash Flow | 17.26 | 47.61 | -12.37 | -154.27 | 161.83 | 82.04 |
Free Cash Flow | 15.28 | 32.68 | -222.2 | -193.2 | -40.23 | -11.81 |
Free Cash Flow Margin | 1.91% | 4.41% | -48.72% | -44.41% | -10.17% | -3.06% |
Free Cash Flow Per Share | 0.10 | 0.21 | -1.40 | -1.22 | -0.26 | -0.08 |
Cash Income Tax Paid | 5.21 | 11.44 | 29.95 | 7.42 | 17.54 | 34.69 |
Levered Free Cash Flow | -75.14 | -42.98 | -239.08 | -252.24 | -83.39 | -50.55 |
Unlevered Free Cash Flow | -75.14 | -42.98 | -231.71 | -246.57 | -81.36 | -50.45 |
Change in Working Capital | -73.71 | -73.71 | -88.27 | -33.75 | -1.52 | -34.35 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.